Orient EuroPharma Statistics
Total Valuation
TPEX:4120 has a market cap or net worth of TWD 3.89 billion. The enterprise value is 5.72 billion.
| Market Cap | 3.89B |
| Enterprise Value | 5.72B |
Important Dates
The last earnings date was Tuesday, November 11, 2025.
| Earnings Date | Nov 11, 2025 |
| Ex-Dividend Date | Jul 7, 2025 |
Share Statistics
TPEX:4120 has 86.75 million shares outstanding. The number of shares has decreased by -0.23% in one year.
| Current Share Class | 86.75M |
| Shares Outstanding | 86.75M |
| Shares Change (YoY) | -0.23% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 14.72% |
| Owned by Institutions (%) | 1.41% |
| Float | 31.56M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.86 |
| PB Ratio | 0.49 |
| P/TBV Ratio | 0.57 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 151.53, with an EV/FCF ratio of -25.05.
| EV / Earnings | -12.35 |
| EV / Sales | 1.26 |
| EV / EBITDA | 151.53 |
| EV / EBIT | n/a |
| EV / FCF | -25.05 |
Financial Position
The company has a current ratio of 1.65, with a Debt / Equity ratio of 0.36.
| Current Ratio | 1.65 |
| Quick Ratio | 1.10 |
| Debt / Equity | 0.36 |
| Debt / EBITDA | 30.73 |
| Debt / FCF | -12.55 |
| Interest Coverage | -1.18 |
Financial Efficiency
Return on equity (ROE) is -5.86% and return on invested capital (ROIC) is -0.60%.
| Return on Equity (ROE) | -5.86% |
| Return on Assets (ROA) | -0.52% |
| Return on Invested Capital (ROIC) | -0.60% |
| Return on Capital Employed (ROCE) | -1.06% |
| Revenue Per Employee | 13.37M |
| Profits Per Employee | -1.37M |
| Employee Count | 339 |
| Asset Turnover | 0.37 |
| Inventory Turnover | 2.03 |
Taxes
In the past 12 months, TPEX:4120 has paid 231.32 million in taxes.
| Income Tax | 231.32M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -7.96% in the last 52 weeks. The beta is 0.21, so TPEX:4120's price volatility has been lower than the market average.
| Beta (5Y) | 0.21 |
| 52-Week Price Change | -7.96% |
| 50-Day Moving Average | 47.85 |
| 200-Day Moving Average | 50.03 |
| Relative Strength Index (RSI) | 34.76 |
| Average Volume (20 Days) | 24,997 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPEX:4120 had revenue of TWD 4.53 billion and -463.18 million in losses. Loss per share was -5.34.
| Revenue | 4.53B |
| Gross Profit | 2.20B |
| Operating Income | -103.04M |
| Pretax Income | -171.85M |
| Net Income | -463.18M |
| EBITDA | 51.54M |
| EBIT | -103.04M |
| Loss Per Share | -5.34 |
Balance Sheet
The company has 2.07 billion in cash and 2.87 billion in debt, giving a net cash position of -797.59 million or -9.19 per share.
| Cash & Cash Equivalents | 2.07B |
| Total Debt | 2.87B |
| Net Cash | -797.59M |
| Net Cash Per Share | -9.19 |
| Equity (Book Value) | 7.89B |
| Book Value Per Share | 79.04 |
| Working Capital | 1.74B |
Cash Flow
In the last 12 months, operating cash flow was -39.11 million and capital expenditures -189.34 million, giving a free cash flow of -228.45 million.
| Operating Cash Flow | -39.11M |
| Capital Expenditures | -189.34M |
| Free Cash Flow | -228.45M |
| FCF Per Share | -2.63 |
Margins
Gross margin is 48.56%, with operating and profit margins of -2.27% and -10.22%.
| Gross Margin | 48.56% |
| Operating Margin | -2.27% |
| Pretax Margin | -3.79% |
| Profit Margin | -10.22% |
| EBITDA Margin | 1.14% |
| EBIT Margin | -2.27% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 1.00, which amounts to a dividend yield of 2.25%.
| Dividend Per Share | 1.00 |
| Dividend Yield | 2.25% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | n/a |
| Buyback Yield | 0.23% |
| Shareholder Yield | 2.48% |
| Earnings Yield | -11.91% |
| FCF Yield | -5.87% |
Stock Splits
The last stock split was on July 28, 2010. It was a forward split with a ratio of 1.16.
| Last Split Date | Jul 28, 2010 |
| Split Type | Forward |
| Split Ratio | 1.16 |
Scores
TPEX:4120 has an Altman Z-Score of 1.52 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.52 |
| Piotroski F-Score | 4 |